Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 4
Submit an article Journal homepage
83
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Humoral Immunodeficiency in Chronic Lymphocytic Leukemia: Role of CD95/CD95L in Tumoral Damage and Escape

Almudena Sampalo Servicio de Inmunología, Hospital Universitario Puerta del Mar, Avenida Ana de Viya 21, 11009 Cádiz, Spain
&
José A Brieva Servicio de Inmunología, Hospital Universitario Puerta del Mar, Avenida Ana de Viya 21, 11009 Cádiz, Spain
Pages 881-884 | Published online: 01 Jul 2009

  • Sampalo, A., Navas, G., Medina, F., Segundo, C., Camara, C. and Brieva, J.A. (2000) "Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction", Blood 96. 3168-3174.
  • Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C. and Binet. J.L. (1991) "B-cell chronic lymphocytic leukemia: present status and future directions", Blood 78, 1901-1910.
  • O'Brien, S., del Giglio, A. and Keating, M. (1995) "Advances in the biology and treatment of B cell chronic lymphatic leukaemia'. Blood 85, 307-318.
  • Hardy, R.R. and Hayakawa, K. (1994) "CD5 B cells, a letal B cell lineage", Adv. Immunol. 55, 297-339.
  • Youinou, P., Jamin, C. and Lydyard, P.M. (1991) "CDS expression in human B cell populations", Immunol. Today 1920, 312-316.
  • Rozman, C. and Monserrat, E. (1995) "Chronic lymphocytic leukaemia", New Eng. J. Med. 333, 1052-1057.
  • Chapel, H. (1987) "Hypogammaglobulinemia and chronic lymphocytic leukaemia", In: Gale, R.P. and Kai, KR., eds. Chronic Lymphocytic Leukemia: Recent Progress and future Directions Proceedings of UCLA Symposia on Molecular and Cell Biology (Liss, New York), pp 383-384.
  • Clone, I., and Uhr, J.W. (1964) "Immunological deficiency disorders associated with chronic lymphocytic leukaemia and multiple myeloma", J. Clin. Invest. 43, 2241-2247.
  • Chapel, H. and Buch, C. (1987) "Mechanism of infections in chronic lymphatic leukaemia", Semin. Hematol. 24, 291-296.
  • Fiddes, P., Penny, R. and Wells, J.V. (1972) "Clinical correlations with immunoglobulin levels in chronic lymphatic leukaemia", Aust NZ J. Med 2, 346-350.
  • Kay, N.K. (1981) "Abnormal T-cell subpopulation function in CLL, Excessive suppressor and deficient helper (T) activity with respect to B-cell proliferation", Blood 57, 418-420.
  • Chiorazzi, N., Fu, S.M., Moniazeri, G., Kunkel, H.G., Rai, K. and Gee, T (1979) "T cell helper defect in patients with chronic lymphocytic leukaemia", J. Immunol 122, 1087-1090.
  • Kurec, A.S. and Davey, F.R. (1987) "Impaired synthesis of immunoglobulin in patients with chronic lymphocytic leukemia", Am. J. Hematol. 25, 131-142.
  • Kay, N.E. and Perry, R.T. (1989) "Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglohulin synthesis", Blood 73, 1016-1019.
  • Cheson, B.D., Bennet, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. and Rai, K.R. (1996) "National Cancer Institute sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood 87, 4990-4997.
  • Shimoni, A., Marcus, H., Canaan, A., Ergas, D., David, M., Berrebi, A. and Reisner, Y. (1997) "A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: Evidence for tumor-mediated suppression of antibody production in low stage disease", Blood 89, 2210-2218.
  • Tinhoffer, I., Marschitz, I., Koss, M., et al. (1998) "Differential sensitivity of CD4+ and CD8- T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand tumor cells in B chronic lymphocytic leukemia", Blood 91, 4273-4281.
  • Nagata, S. and Golstein, P. (1995) "The Fas death receptor", Sceince 267, 1449-1456.
  • Cerutti, A., Kiml, E.C., Shah, S., et al. (2001) "Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells", Nature Immunol. 2, 150-156.
  • Cantwell, M., Hua, T., Pappas, J. and Kipps, T.J (1997) "Acquired CD40-ligand deficiency in chronic lymphatic leukemia", Nature Med. 3, 984-989.
  • Slavnezer, J. (1996) "Antibody class switching", Adv. Immunol 61, 79-146.
  • Lacombe, C., Gombert, J., Dreyfus, B., Brizard, A. and Preud'Homme, J.L. (1999) "Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia", Clin. Immunol. 90, 128-132.
  • Macmillan, R., Longmire, R.L., Yelenosky, K., Lang, J.H., Heath, V. and Craddok, C.G. (1972) "Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production" J. Immunol. 109, 1386-1394.
  • Benner R., Hijmans, W. and Haaijman, J.J. (1981) "The bone marrow: the major source of immunoglobulins, but still neglected site of antibody formation", Clin. Exp. Immunol. 46,1-8.
  • Leithauser, F., Dhein, H., Mechtersheimer, G., Koretz, K., Bruederlein, S., Henn, C., Schmidt, A., Debatin, K.M., Krammer, P.H. and Moeller, P. (1993) "Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily in normal and neoplastic cells", Lab. Invest. 69, 415-429.
  • Abbas, A.K. (1996) "Die and let live: eliminating dangerous lymphocytes", Cell 84, 655-657.
  • Medina, F., Segundo, C., Rodriguez, C. and Brieva, J.A. (1997) "Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and high rate Ig secretion", Eur. J. Immunol. 27, 700-706.
  • Ashwelt, J.D. Berger, N.A., Cidlowski, J.A., Lane, D.P. Korsmeyer, S.J. and Ashwell, J.D. (1994) "Coming to terms with death: apoptosis in cancer and immune development", Immunol. Today 15, 147-151.
  • Nagata, S. and Suda, P. (1995) "Fas and fas-ligand: lpr and gld mutations", Immunol. Today. 16, 39-43.
  • Fisher, G.H., Rosenberg, F.J., Strauss, S.E., Dale, J.K., Middelton, L. A., Linn. A.Y, Stroher, W., Lenardo, M.J. and Puck, J.M. (1995) "Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome", Cell 81, 935-946.
  • O'Connell, J. Houston, A. Bennet, M.W., O'Sullivan, G.C. and Shanahan, F. (2001) "Immune privilege or inflammation? Insights into the fas ligand enigma", Nature Med. 7, 271-274.
  • Stassy, G., Liberto, D., Todaro, M., Zeuner, A., Ricci-Vittani, L., Stoppacioro, A., Ruco, L., farina, F., Zummo, G. and De Maria, R. (2000) "Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins", Nature Immunol. 1, 461-462.
  • Viard, I., Wehrli, P. Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Jean-Hilaire S., Tschoop, J. and French, L.S. (1998) "Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin", Science 282490-282493.
  • Ryo, K., Kamogawa, Y., Ikeda, I., Yamauchi, K., Yonchara, S., Nagata, S. and Hayasahi, N. (2000) "Significance of Fas antigen mediated apoptosis in human fulminant hepatic failure", Am. J. Gastroenterol. 95, 2047-2055.
  • Silvestris, F., Tucci, M., Cafforio, P. and Dammaco, F. (2001) "Fas-L upregulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression", Blood 97, 1155-1164.
  • Andreef, M., Darzynkiewicz, S., Sharpless, T.K., Clarkson, B.D. and Melamed, M.R. (1988) "Discrimination of human leukaemia subtypes by flow cytometer analysis of cellular DNA and RNA", Blood 55, 282-293.
  • Reed, C.J (2000) "Apoptosis and cancer: strategies for integrating programmed cell death", Semin. Hematol. 37(4 suppl. 7), 9-16.
  • Villunger, A., Egle, A. and Marschitz, I. (1997) "Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of rumor-induced suppression of immune surveillance", Blood 90, 12-20.
  • O'Connell, J., O'Sullivan, J.K. and Shanahan, F. (1996) "The fas counterattack: Fas-mediated T cell killing by colon cancer expressing Fas ligand", J. Exp. Med. 184, 1075-1082.
  • Hane, M., Rimoldi, D., Schroter, M., et al. (1996) "Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape", Science 274, 1363-1366.
  • Saas, P., Walker, P.R., Hahne, M., et al., (1997) "Fas-ligand expression by astrocytonia in vivo: maintaining immune privilege in the brain?", J. Clin. Invest. 99. 1173-1178.
  • Ito, Y., Monden, M., Takeda, T., Eguchi, H., Umeshita, K., Hagano, H., et al., (2000) "The status of Fas and Fas-ligand expression can predict recurrence of hepatocellular carcinoma", Br. J. Cancer 82, 1211-1217.
  • Reimer, T., Herrming, C., Koczan, D., Ritcher, D., Gerber, B., Kabelitz, D., Friese, K. and Thiesen, H.J. (2000) "FasL:Fas ratio, a prognostic factor in breast carcinoma", Cancer Res. 60, 822-828.
  • Munakata, S., Enomoto, T., Tsujimoto, M., Otsuki, Y., Miwa, H., Kanno, H. and Aozasa, K. (2000) "Expression of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms", Br. J. Cancer 82, 1446-1452.
  • Mann, B., Gratchev, A., Bohm, C., Hanski, M.L. Foss, H.D., Demel, G., Trojanck, B., Schmidt-Wolf, I., Stem, H., Riccken, E.O., Buhr, H.J. and Hanski, C. (1999) "Fast, is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas", Br. J Cancer 79, 1262-1269.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.